CirTran Corporation 2025 Annual Report: Key Insights and Shareholder Alerts

Executive Summary

CirTran Corporation has released its annual report for the fiscal year ended December 31, 2025. The report reveals the company’s ongoing operational challenges, significant financial uncertainties, and its efforts to reposition in various consumer product markets. Investors and shareholders should carefully consider the following highlights, as several items may have a direct impact on CirTran’s share value.

Key Points from the Annual Report

1. Going Concern Warning

• Substantial Doubt About Company’s Future: The independent auditor’s report contains an explanatory paragraph raising substantial doubt about CirTran’s ability to continue as a going concern. The company has a working capital deficiency, accumulated deficit, and continues to post net losses from operations. There are no adjustments in the financial statements to address this uncertainty.
• Accumulated Deficit: As of December 31, 2025, CirTran’s accumulated deficit was approximately \$62.3 million.

2. Financial Performance and Liquidity

• History of Losses: CirTran has suffered substantial losses, with the future of the company dependent on its ability to generate sufficient revenue or recover start-up costs from its GloBrands-HUSTLER® Exclusive Manufacturing and Distribution Agreement.
• Operating Expenses: Selling, general, and administrative expenses increased by 33% from \$873,570 in 2024 to \$1,161,867 in 2025. This increase was primarily due to additional marketing expenses for new product launches in retail chains.
• Discontinued Operations: Losses from discontinued operations were \$153,466 in 2025 and \$153,886 in 2024, mainly due to interest expense.
• Monthly Operating Costs: The company’s monthly operating costs are approximately \$35,000, excluding about \$50,000 per month in accruing interest and capital expenditures.
• Reliance on External Funding: CirTran has only recently generated enough cash to meet day-to-day operations and expects to rely on external capital for future projects.
• Convertible Debt: All company assets are encumbered to secure indebtedness convertible to common stock. If this debt is not converted before April 2027, default could result in loss of all assets. The main debenture is with Tekfine, LLC, with a principal balance of \$2.4 million and accrued interest of \$2.2 million. These debentures are convertible at extremely low prices, which could significantly dilute existing shareholders.
• Equity Compensation: As of December 31, 2025, there were 24,000 securities to be issued upon exercise of outstanding options, warrants, and rights, with a weighted-average exercise price of \$0.01 and 344,000 securities available for future issuance.

3. Business Overview and Risks

• New Operations and Strategic Shift: CirTran is focused on manufacturing, marketing, and distributing consumer products, including tobacco products, medical devices, and beverages, in more than 50 key international markets. The company’s operations restarted in 2020 after severe operational and legal hurdles in 2016 that significantly curtailed activities.
• Operational Risks: The company faces typical risks of new businesses, including establishing reliable product sources, building supply and distribution chains, and developing management capabilities.
• Growth Management: Any significant increase in business activities will require skilled management of growth, which is a risk factor due to their limited resources.
• Penny Stock Regulation: CirTran’s common stock is quoted on the Pink tier of the OTC Markets Group under the symbol “CIRX” and is classified as a “penny stock.” This subjects the stock to additional sales practice requirements, which may restrict trading and liquidity and further depress share prices.
• No Dividends: The company has not paid dividends and intends to retain earnings, if any, to finance business development and expansion. Future dividends, if any, are at the discretion of the Board.
• Minimal Full-Time Staff: As of December 31, 2025, CirTran employed only four full-time employees (including officers and directors) and 23 part-time contract workers, relying heavily on contract and part-time labor to minimize fixed overhead.

4. Compliance and Reporting Status

• CirTran is not a well-known seasoned issuer, nor is it a voluntary filer.
• The company has filed all reports required by the Exchange Act for the preceding 12 months and submitted all required electronic interactive data files.
• CirTran is classified as a smaller reporting company and is not required to provide certain disclosures, such as market risk analysis, beyond the basics.
• The company is not classified as an emerging growth company or a shell company.

5. Cybersecurity Disclosure

• CirTran disclosed its cybersecurity risk management and strategy. There is no indication that cybersecurity risks have materially affected or are reasonably likely to materially affect the company’s business, results of operations, or financial condition.

Potentially Price-Sensitive Items for Shareholders

• Going Concern Doubt: The auditor’s warning about the company’s ability to continue as a going concern is a serious red flag. If the company cannot secure additional funding or generate sufficient revenue, it may not survive.
• Convertible Debt Overhang: The large amount of convertible debt, if converted at low prices, could lead to massive dilution for existing shareholders and further pressure the stock price.
• Penny Stock Status: Ongoing classification as a penny stock may continue to limit liquidity and trading interest, and could further depress the share price.
• Dependence on External Capital: The company’s need for external capital, with limited access to traditional debt markets, means that future fundraising could be dilutive and may be on unfavorable terms.
• No Recent Sales of Unregistered Securities: There have been no recent sales of unregistered securities, which may be positive in terms of dilution but also suggests limited fundraising activity.

Conclusion for Investors

CirTran Corporation’s 2025 annual report presents a company at a crossroads. While management is working to revive operations and expand its footprint, persistent losses, severe dilution risk, and a dire need for external funding mean that shareholders face significant risks. The auditor’s going concern warning, in particular, should not be taken lightly. Investors should exercise extreme caution and closely monitor future disclosures, financing developments, and operational execution.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult their financial advisor before making any investment decisions. The company discussed herein is subject to high risks and volatility.

View CIRTRAN CORP Historical chart here